• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 3. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 4. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 5. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699

Introduction to 4-Tert-butyl-1,3-oxazole (CAS No. 52713-54-9)

4-Tert-butyl-1,3-oxazole, identified by the Chemical Abstracts Service Number (CAS No.) 52713-54-9, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical and chemical research due to its unique structural properties and potential applications. This compound belongs to the oxazole class, which is characterized by a five-membered ring containing two oxygen atoms and one nitrogen atom. The presence of a tert-butyl substituent at the 4-position of the oxazole ring introduces steric and electronic effects that make this molecule of particular interest for further exploration.

The structural motif of 4-Tert-butyl-1,3-oxazole contributes to its distinct chemical behavior, influencing both its reactivity and its potential biological activity. The tert-butyl group not only enhances the hydrophobicity of the molecule but also acts as a steric barrier, which can modulate interactions with biological targets. This feature has been exploited in various research settings, where fine-tuning of molecular interactions is crucial for developing novel therapeutic agents.

In recent years, there has been a growing interest in oxazole derivatives as pharmacophores due to their broad spectrum of biological activities. Oxazoles are known to exhibit properties such as antimicrobial, anti-inflammatory, and antioxidant effects. The introduction of the tert-butyl group in 4-Tert-butyl-1,3-oxazole may further enhance these properties by influencing the molecule's solubility, stability, and binding affinity to biological targets. This has prompted researchers to investigate its potential in drug discovery and development.

One of the most compelling aspects of 4-Tert-butyl-1,3-oxazole is its versatility as a building block for more complex molecules. The oxazole ring can serve as a scaffold for designing novel compounds with tailored properties. For instance, modifications at other positions on the oxazole ring or the introduction of additional functional groups can lead to derivatives with enhanced biological activity or improved pharmacokinetic profiles. This flexibility makes 4-Tert-butyl-1,3-oxazole a valuable asset in synthetic chemistry and medicinal chemistry.

Recent studies have highlighted the importance of understanding the electronic and steric effects introduced by substituents like the tert-butyl group in oxazole derivatives. Computational studies have shown that the tert-butyl substituent can significantly influence the electronic distribution within the molecule, thereby affecting its reactivity and interaction with biological targets. These insights are crucial for designing molecules with specific desired properties.

The synthesis of 4-Tert-butyl-1,3-oxazole typically involves multi-step organic reactions that require careful optimization to achieve high yields and purity. Common synthetic routes include cyclization reactions followed by functional group transformations to introduce the tert-butyl moiety. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making it feasible to explore the compound's potential in various applications.

Beyond its pharmaceutical applications, 4-Tert-butyl-1,3-oxazole has shown promise in material science and industrial chemistry. Its unique structural features make it a candidate for developing novel polymers, coatings, and other specialty chemicals. The ability to modify its structure allows researchers to tailor its properties for specific industrial uses.

The biological activity of 4-Tert-butyl-1,3-oxazole has been studied in several contexts. Preliminary experiments suggest that it may exhibit inhibitory effects on certain enzymes and receptors relevant to inflammatory diseases and cancer. While these findings are promising, further research is needed to fully elucidate its mechanism of action and potential therapeutic applications.

In conclusion,4-Tert-butyl-1,3-oxazole (CAS No. 52713-54-9) is a structurally interesting compound with significant potential in pharmaceutical research and beyond. Its unique combination of electronic and steric effects makes it a valuable scaffold for designing novel molecules with tailored properties. As research continues to uncover new applications for this compound,4-Tert-butyl-1,3-oxazole is likely to play an increasingly important role in both academic and industrial settings.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)